Elsevier

The Lancet

Volume 368, Issue 9532, 22–28 July 2006, Pages 262-266
The Lancet

Comment
Funding for practice-oriented clinical research

https://doi.org/10.1016/S0140-6736(06)69010-7Get rights and content

First page preview

First page preview
Click to open first page preview

References (20)

  • R Horton

    Health research in the UK: the price of success

    Lancet

    (2006)
  • SC Johnston et al.

    Effect of a US National Institutes of Health programme of clinical trials on public health and costs

    Lancet

    (2006)
  • JW Gardner

    Excellence, can we be equal and excellent too?

    (1995)
  • UK health research analysis: the first national analysis of health research in the UK

  • I Chalmers et al.

    descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980–2002

    BMJ

    (2003)
  • PM Rothwell

    Medical academia is failing patients and clinicians: the neglect of basic observational clinical research

    BMJ

    (2006)
  • J Rees

    The fundamentals of clinical discovery

    Perspect Biol Med

    (2004)
  • Strengthening clinical research

  • AL Cochrane

    Effectiveness and efficiency: random reflections on health services

    (1972)
  • Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care

There are more references available in the full text version of this article.

Cited by (35)

  • Potentials for research and innovations in allied health professions in Germany

    2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
  • Increasing value and reducing waste in biomedical research regulation and management

    2014, The Lancet
    Citation Excerpt :

    Extended application of this policy would help to achieve greater integration of research within routine care. Inevitably, prioritisation of practice-oriented clinical research requires further shifts in the distribution of research funds.96 There are opportunity costs of wasteful regulation and management of research.

  • How to increase value and reduce waste when research priorities are set

    2014, The Lancet
    Citation Excerpt :

    Global investment in biomedical research is increasing, reaching US$240 billion (adjusted for purchasing power parity) in 2010.5 Basic research is the principal beneficiary of this investment.6 More than half of the £1·6 billion in public and charitable investment in research in the UK in 2009–10 was allocated to basic research (table 1),7 a pattern that was also reported in the USA in 2012.8

View all citing articles on Scopus
View full text